Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 217650
Company: TEVA PHARM
Company: TEVA PHARM
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| SHEUR | ELAGOLIX, ESTRADIOL AND NORETHINDRONE ACETATE AND ELAGOLIX | 300MG/1MG/0.5MG | CAPSULE | Prescription | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 09/22/2025 | ORIG-1 | Tentative Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/217650Orig1s000TAltr.pdf |